Nemean Asset Management, LLC

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

Stocks Covered

Latest Filing

Jan 11, 2025

Filings

FBRX

Forte Biosciences, Inc.

SC 13G · Jan 11, 2025

6.8%

432K shares

BNTC

SC 13G 1 tm2412949d1_sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Benitec Biopharma Inc.

SC 13G · Apr 29, 2024

8.4%

746K shares

BNTC

(Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Benitec Biopharma Inc.

SC 13G/A · Aug 18, 2023

3.9%

98K shares

BNTC

(Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Benitec Biopharma Inc.

SC 13G/A · Oct 7, 2022

3.9%

1.0M shares

N/A

(Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Ignyte Acquisition Corp.

SC 13G/A · May 9, 2022

0.0%

0 shares

TRVI

SC 13G 1 tm228744d1_sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 Trevi Therapeutics, Inc.

SC 13G · Mar 9, 2022

1.4%

360K shares